Morgan Stanley Sees Another Solid Year Ahead for Becton, Dickinson and Co.
In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Becton, Dickinson and Co. (NYSE: BDX).
In the report, Morgan Stanley noted, “Our more bullish tone into FY14 was driven by multi-year investments that have begun to impact top and bottom line results. We continue to expect modest upside through the year and see additional potential acceleration from generic injectables, diabetes, SG&A leverage, and M&A.”
Becton, Dickinson and Co. closed on Tuesday at $106.01.
Latest Ratings for BDX
|Mar 2015||Goldman Sachs||Reinstates||Neutral|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.